Professional Summary
Education & Certifications
- Medical Education: Washington University School Of Medicine (2005) MO
- Residency: Washington University Dept of Radiation Oncology (2010) MO
- Internship: Washington University Barnes Jewish Hospital Internal Medicine Residency (2006) MO
-
- Board Certification: American Board of Radiology, Radiation Oncology (2011)
Publications
-
Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer
Kidd, E. A., Yu, J. S., Li, X., Shannon, W. D., Watson, M. A., & McLeod, H. L. (2005). Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer. CLINICAL CANCER RESEARCH, 11(7), 2612–2619. -
The efficacy of radiation therapy in the management of grade I astrocytomas
Kidd, E. A., Mansur, D. B., Leonard, J. R., Michalski, J. M., Simpson, J. R., & Perry, A. (2006). The efficacy of radiation therapy in the management of grade I astrocytomas. JOURNAL OF NEURO-ONCOLOGY, 76(1), 55–58. -
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
Kidd, E. A., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2007). The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. CANCER, 110(8), 1738–1744. -
-
Intratumoral metabolic heterogeneity of cervical cancer
Kidd, E. A., & Grigsby, P. W. (2008). Intratumoral metabolic heterogeneity of cervical cancer. CLINICAL CANCER RESEARCH, 14(16), 5236–5241. -
Cervical Cancer Histology and Tumor Differentiation Affect F-18-Fluorodeoxyglucose Uptake
Kidd, E. A., Spencer, C. R., Huettner, P. C., Siegel, B. A., Dehdashti, F., Rader, J. S., & Grigsby, P. W. (2009). Cervical Cancer Histology and Tumor Differentiation Affect F-18-Fluorodeoxyglucose Uptake. CANCER, 115(15), 3548–3554. -
CLINICAL OUTCOMES OF DEFINITIVE INTENSITY-MODULATED RADIATION THERAPY WITH FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY SIMULATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
Kidd, E. A., Siegel, B. A., Dehdashti, F., Rader, J. S., Mutic, S., Mutch, D. G., … Grigsby, P. W. (2010). CLINICAL OUTCOMES OF DEFINITIVE INTENSITY-MODULATED RADIATION THERAPY WITH FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY SIMULATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 77(4), 1085–1091. -
Pelvic Lymph Node F-18 Fluorodeoxyglucose Uptake as a Prognostic Biomarker in Newly Diagnosed Patients With Locally Advanced Cervical Cancer
Kidd, E. A., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2010). Pelvic Lymph Node F-18 Fluorodeoxyglucose Uptake as a Prognostic Biomarker in Newly Diagnosed Patients With Locally Advanced Cervical Cancer. CANCER, 116(6), 1469–1475. -
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.
El Naqa, I., Grigsby, P., Apte, A., Kidd, E., Donnelly, E., Khullar, D., … Deasy, J. O. (2009). Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognition, 42(6), 1162–1171. -
Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis
Kidd, E. A., Dehdashti, F., Siegel, B. A., & Grigsby, P. W. (2010). Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis. RADIOTHERAPY AND ONCOLOGY, 95(3), 288–291. -
Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis
Kidd, E. A., Siegel, B. A., Dehdashti, F., Rader, J. S., Mutch, D. G., Powell, M. A., & Grigsby, P. W. (2010). Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis. JOURNAL OF CLINICAL ONCOLOGY, 28(12), 2108–2113. -
RADIATION THERAPY FOR PILOCYTIC ASTROCYTOMAS OF CHILDHOOD
Mansur, D. B., Rubin, J. B., Kidd, E. A., King, A. A., Hollander, A. S., Smyth, M. D., … Leonard, J. R. (2011). RADIATION THERAPY FOR PILOCYTIC ASTROCYTOMAS OF CHILDHOOD. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(3), 829–834. -
Changes in Cervical Cancer FDG Uptake During Chemoradiation and Association With Response
Kidd, E. A., Thomas, M., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2013). Changes in Cervical Cancer FDG Uptake During Chemoradiation and Association With Response. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85(1), 116–22. -
FDG-PET-based prognostic nomograms for locally advanced cervical cancer
Kidd, E. A., El Naqa, I., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2012). FDG-PET-based prognostic nomograms for locally advanced cervical cancer. GYNECOLOGIC ONCOLOGY, 127(1), 136–40. -
ACR Appropriateness Criteria (R) Definitive Therapy for Early-Stage Cervical Cancer
Small, W., Strauss, J. B., Jhingran, A., Yashar, C. M., Cardenes, H. R., Erickson-Wittmann, B. A., … Gaffney, D. K. (2012). ACR Appropriateness Criteria (R) Definitive Therapy for Early-Stage Cervical Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(4), 399–405. -
ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva.
Kidd, E., Moore, D., Varia, M. A., Gaffney, D. K., Elshaikh, M. A., Erickson, B., … Cardenes, H. R. (2013). ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. American Journal of Clinical Oncology, 36(4), 415–22. -
Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes.
Hiniker, S. M., Roux, A., Murphy, J. D., Harris, J. P., Tran, P. T., Kapp, D. S., & Kidd, E. A. (2013). Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes. Gynecologic Oncology, 131(2), 380–85. -
Treatment approach and outcomes of vaginal melanoma.
Kirschner, A. N., Kidd, E. A., Dewees, T., & Perkins, S. M. (2013). Treatment approach and outcomes of vaginal melanoma. International Journal of Gynecological Cancer , 23(8), 1484–89. -
Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy.
Bazan, J. G., Luxton, G., Kozak, M. M., Anderson, E. M., Hancock, S. L., Kapp, D. S., … Chang, D. T. (2013). Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 87(5), 983–91. -
ACR APPROPRIATENESS CRITERIA (R) Management of Vaginal Cancer
Lee, L. J., Jhingran, A., Kidd, E., Cardenes, H. R., Elshaikh, M. A., Erickson, B., … Gaffney, D. K. (2013). ACR APPROPRIATENESS CRITERIA (R) Management of Vaginal Cancer. ONCOLOGY-NEW YORK, 27(11), 1166–73. -
Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California.
Froment, M.-A., Gomez, S. L., Roux, A., DeRouen, M. C., & Kidd, E. A. (2014). Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California. Gynecologic Oncology, 133(3), 409–15. -
ACR Appropriateness Criteria® Advanced Stage Endometrial Cancer.
Elshaikh, M. A., Yashar, C. M., Wolfson, A. H., Cardenes, H. R., Erickson, B., Jhingran, A., … Gaffney, D. K. (2014). ACR Appropriateness Criteria® Advanced Stage Endometrial Cancer. American Journal of Clinical Oncology, 37(4), 391–96. -
More Accurate Definition of Clinical Target Volume Based on the Measurement of Microscopic Extensions of the Primary Tumor Toward the Uterus Body in International Federation of Gynecology and Obstetrics Ib-IIa Squamous Cell Carcinoma of the Cervix
Xie, W.-J., Wu, X., Xue, R.-L., Lin, X.-Y., Kidd, E. A., Yan, S.-M., … Xie, L.-X. (2015). More Accurate Definition of Clinical Target Volume Based on the Measurement of Microscopic Extensions of the Primary Tumor Toward the Uterus Body in International Federation of Gynecology and Obstetrics Ib-IIa Squamous Cell Carcinoma of the Cervix. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 91(1), 206–12. -
More accurate definition of clinical target volume based on the measurement of microscopic extensions of the primary tumor toward the uterus body in international federation of gynecology and obstetrics Ib-IIa squamous cell carcinoma of the cervix.
Xie, W.-J., Wu, X., Xue, R.-L., Lin, X.-Y., Kidd, E. A., Yan, S.-M., … Xie, L.-X. (2015). More accurate definition of clinical target volume based on the measurement of microscopic extensions of the primary tumor toward the uterus body in international federation of gynecology and obstetrics Ib-IIa squamous cell carcinoma of the cervix. International Journal of Radiation Oncology, Biology, Physics, 91(1), 206–12. -
Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
Pollom, E. L., Conklin, C. M. J., von Eyben, R., Folkins, A. K., & Kidd, E. A. (2016). Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer. International Journal of Gynecological Pathology , 35(5), 395–401. -
ACR Appropriateness Criteria (R) Adjuvant Therapy in Vulvar Cancer
Jolly, S., Soni, P., Gaffney, D. K., Biagioli, M., Elshaikh, M. A., Jhingran, A., … Small, W. (2015). ACR Appropriateness Criteria (R) Adjuvant Therapy in Vulvar Cancer. ONCOLOGY-NEW YORK, 29(11), 867-? -
ACR Appropriateness Criteria (R) Adjuvant Management of Early-Stage Endometrial Cancer
Wahl, A. O., Gaffney, D. K., Jhingran, A., Yashar, C. M., Biagioli, M., Elshaikh, M. A., … Small, W. (2016). ACR Appropriateness Criteria (R) Adjuvant Management of Early-Stage Endometrial Cancer. ONCOLOGY-NEW YORK, 30(9), 816–22. -
ACR Appropriateness Criteria (R) Management of Recurrent Endometrial Cancer
Elshaikh, M. A., Vance, S., Gaffney, D. K., Biagioli, M., Jhingran, A., Jolly, S., … Small, W. (2016). ACR Appropriateness Criteria (R) Management of Recurrent Endometrial Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 39(5), 507–15. -
Consideration of patient and disease characteristics in selecting radiation regimens for treatment of bone metastases.
Liu, Y., von Eyben, R., & Kidd, E. A. (2017). Consideration of patient and disease characteristics in selecting radiation regimens for treatment of bone metastases. Practical Radiation Oncology. -
Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient
Nwachukwu, C. R., Von-Eyben, R., & Kidd, E. A. (2018). Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient. BRACHYTHERAPY, 17(2), 383–91. -
Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma
Qian, Y., Pollom, E. L., Nwachukwu, C., Seiger, K., von Eyben, R., Folkins, A. K., & Kidd, E. A. (2017). Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma. GYNECOLOGIC ONCOLOGY, 147(1), 24–29. -
Rate of Change in Quantitative PET/CT Metrics Prior to Definitive Chemoradiotherapy for Cervical Cancer Does not Add Prognostic Information Over Single Time Point Metrics
Prionas, N. D., von Eyben, R., Hristov, D., & Kidd, E. (2018). Rate of Change in Quantitative PET/CT Metrics Prior to Definitive Chemoradiotherapy for Cervical Cancer Does not Add Prognostic Information Over Single Time Point Metrics. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101(2), E31–E32. -
Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Banks, T. I., von Eyben, R., Hristov, D., & Kidd, E. A. (2018). Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response. Cancer Medicine. -
Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline.
Chuang, L. T., Temin, S., Camacho, R., Duenas-Gonzalez, A., Feldman, S., Gultekin, M., … Berek, J. S. (2016). Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline. Journal of Global Oncology, 2(5), 311–40. -
Less than whole uterus irradiation for locally advanced cervical cancer maintains locoregional control and decreases radiation dose to bowel.
Kozak, M. M., Koenig, J. L., von Eyben, R., & Kidd, E. A. (2018). Less than whole uterus irradiation for locally advanced cervical cancer maintains locoregional control and decreases radiation dose to bowel. Practical Radiation Oncology. -
Improving brachytherapy efficiency with dedicated dosimetrist planners.
Fujimoto, D. K., von Eyben, R., Usoz, M., & Kidd, E. A. (2018). Improving brachytherapy efficiency with dedicated dosimetrist planners. Brachytherapy. -
IMRT and image-guided adapted brachytherapy for cervix cancer.
Lin, A. J., Kidd, E., Dehdashti, F., Siegel, B. A., Mutic, S., Thaker, P. H., … Grigsby, P. W. (2018). IMRT and image-guided adapted brachytherapy for cervix cancer. International Journal of Radiation Oncology, Biology, Physics. -
Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer.
Nwachukwu, C. R., Harris, J. P., Chin, A., Von Eyben, R., Giaretta, S., Shaffer, J. L., … Kidd, E. A. (2018). Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. -
National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
Xiang, M., English, D. P., & Kidd, E. A. (2018). National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma. Gynecologic Oncology. -
Sentinel lymph node biopsies in endometrial cancer - practice patterns among Gynecologic Oncologists in the United States.
Renz, M., Diver, E., English, D., Kidd, E., Dorigo, O., & Karam, A. (2019). Sentinel lymph node biopsies in endometrial cancer - practice patterns among Gynecologic Oncologists in the United States. Journal of Minimally Invasive Gynecology. -
Definitive Radiotherapy with or Without Cisplatin for Cervical Cancer in Older Women
Xiang, M., & Kidd, E. (2019). Definitive Radiotherapy with or Without Cisplatin for Cervical Cancer in Older Women. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 103(5), E11. -
National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma
Xiang, M., English, D. P., & Kidd, E. A. (2019). National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma. GYNECOLOGIC ONCOLOGY, 152(3), 599–604. -
Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang, M., English, D. P., & Kidd, E. A. (2019). Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma. Gynecologic Oncology. -
Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer.
Nwachukwu, C. R., Harris, J. P., Chin, A., Von Eyben, R., Giaretta, S., Shaffer, J. L., … Kidd, E. A. (2019). Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists, 38(6), 588–96. -
Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer
Xiang, M., & Kidd, E. A. (2019). Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 17(8), 969-+. -
Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
Xiang, M., & Kidd, E. A. (2019). Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma. Journal of Gynecologic Oncology. -
Improving gynecologic brachytherapy patient experience by optimizing MRI, anesthesia, and scheduling to decrease the length of time tandem and ovoid applicators are in place.
Usoz, M., von Eyben, R., Fujimoto, D. K., & Kidd, E. A. (2020). Improving gynecologic brachytherapy patient experience by optimizing MRI, anesthesia, and scheduling to decrease the length of time tandem and ovoid applicators are in place. Brachytherapy. -
Sentinel Lymph Node Biopsies in Endometrial Cancer: Practice Patterns among Gynecologic Oncologists in the United States
Renz, M., Diver, E., English, D., Kidd, E., Dorigo, O., & Karam, A. (2020). Sentinel Lymph Node Biopsies in Endometrial Cancer: Practice Patterns among Gynecologic Oncologists in the United States. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 27(2), 482–88. -
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer
Lin, A. J., Kidd, E., Dehdashti, F., Siegel, B. A., Mutic, S., Thaker, P. H., … Grigsby, P. W. (2019). Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 103(5), 1088–97. -
Parametric Response Mapping of Co-registered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radio-resistant Sub-volumes in Locally Advanced Cervical Cancer.
Capaldi, D. P., Hristov, D. H., & Kidd, E. A. (2020). Parametric Response Mapping of Co-registered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radio-resistant Sub-volumes in Locally Advanced Cervical Cancer. International Journal of Radiation Oncology, Biology, Physics. -
Executive summary of the American Radium Society Appropriate Use Criteria for management of uterine carcinosarcoma.
Elshaikh, M. A., Modh, A., Jhingran, A., Biagioli, M. C., Coleman, R. L., Gaffney, D. K., … Small, W. J. (2020). Executive summary of the American Radium Society Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecologic Oncology. -
Intensity modulated Ir-192 brachytherapy using high-Z 3D printed applicators.
Skinner, L. B., Niedermayr, T., Prionas, N., Perl, J., Fahimian, B. P., & Kidd, E. (2020). Intensity modulated Ir-192 brachytherapy using high-Z 3D printed applicators. Physics in Medicine and Biology. -
Improving brachytherapy efficiency with dedicated dosimetrist planners
Fujimoto, D. K., von Eyben, R., Usoz, M., & Kidd, E. A. (2019). Improving brachytherapy efficiency with dedicated dosimetrist planners. BRACHYTHERAPY, 18(1), 103–7. -
Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response
Banks, T. I., von Eyben, R., Hristov, D., & Kidd, E. A. (2018). Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response. CANCER MEDICINE, 7(8), 3642–51. -
Impact of socioeconomic status and degree of ethnic isolation on cervical cancer incidence among Hispanics and Asians in California
Froment, M.-A., Roux, A., DeRouen, M. C., Gomez, S. L., & Kidd, E. A. (2013). Impact of socioeconomic status and degree of ethnic isolation on cervical cancer incidence among Hispanics and Asians in California. JOURNAL OF CLINICAL ONCOLOGY, 31(15). -
The Use of Positron Emission Tomographic Imaging for Image-Guided Therapy
Kidd, E., & Grigsby, P. (2011). The Use of Positron Emission Tomographic Imaging for Image-Guided Therapy. GYNECOLOGIC RADIATION THERAPY: NOVEL APPROACHES TO IMAGE-GUIDANCE AND MANAGEMENT, 41–48. -
Validated limited gene predictor for cervical cancer lymph node metastases.
Bloomstein, J. D., von Eyben, R., Chan, A., Rankin, E. B., Fregoso, D. R., Wang-Chiang, J., … Kidd, E. A. (2020). Validated limited gene predictor for cervical cancer lymph node metastases. Oncotarget, 11(24), 2302–9. -
Prospective Randomized Trial of Email and/or Telephone Reminders to Enhance Vaginal Dilator Compliance in Patients Undergoing Brachytherapy for Gynecologic Malignancies
Kozak, M., Usoz, M., Fujimoto, D., von Eyben, R., & Kidd, E. (2020). Prospective Randomized Trial of Email and/or Telephone Reminders to Enhance Vaginal Dilator Compliance in Patients Undergoing Brachytherapy for Gynecologic Malignancies. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(2), E10. -
Recurrence risk factors in stage IA grade 1 endometrial cancer.
Nwachukwu, C., Baskovic, M., Von Eyben, R., Fujimoto, D., Giaretta, S., English, D., & Kidd, E. (2021). Recurrence risk factors in stage IA grade 1 endometrial cancer. Journal of Gynecologic Oncology. -
Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors.
Rahimy, E., Usoz, M., von Eyben, R., Fujimoto, D., Watanabe, D., Karam, A., … Kidd, E. (2021). Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors. Gynecologic Oncology. -
A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women with Stage IIIC Endometrial Cancer.
Hathout, L., Wang, Y., Wang, Q., Vergalasova, I., Elshaikh, M. A., Dimitrova, I., … Lee, L. J. (2021). A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women with Stage IIIC Endometrial Cancer. International Journal of Radiation Oncology, Biology, Physics. -
Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit.
Xiang, M., English, D. P., & Kidd, E. A. (2021). Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit. Brachytherapy. -
Prospective randomized trial of email and/or telephone reminders to enhance vaginal dilator compliance in patients undergoing brachytherapy for gynecologic malignancies.
Kozak, M. M., Usoz, M., Fujimoto, D., von Eyben, R., & Kidd, E. (2021). Prospective randomized trial of email and/or telephone reminders to enhance vaginal dilator compliance in patients undergoing brachytherapy for gynecologic malignancies. Brachytherapy. -
Limited Time Penalty for Improved Dosimetry: Simplified Needle Insertion in Combined Tandem and Ovoid plus Interstitial Cases with Custom Templates
Niedermayr, T., & Kidd, E. (2021). Limited Time Penalty for Improved Dosimetry: Simplified Needle Insertion in Combined Tandem and Ovoid plus Interstitial Cases with Custom Templates. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS. -
Creation of Appropriate Use Criteria for Management of Uterine Clear Cell and Serous Carcinomas
Sherertz, T., Yashar, C., Jhingran, A., Wahl, A., Elshaikh, M., Coleman, R., … Small, W. (2021). Creation of Appropriate Use Criteria for Management of Uterine Clear Cell and Serous Carcinomas. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS. -
Phase II Trial Evaluating Efficacy of a Fitbit Program for Improving the Health of Endometrial Cancer Survivors
Rahimy, E., Usoz, M., von Eyben, R., Fujimoto, D., Watanabe, D., Karam, A., … Kidd, E. (2021). Phase II Trial Evaluating Efficacy of a Fitbit Program for Improving the Health of Endometrial Cancer Survivors. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS. -
Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience.
Devereaux, K. A., Weiel, J. J., Pors, J., Steiner, D. F., Ho, C., Charu, V., … Howitt, B. E. (2021). Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience. Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. -
Does prophylactic para-aortic lymphatic irradiation improve outcomes in women with stage IIIC1 endometrial carcinoma? A multi-institutional pooled analysis.
Yoon, J., Fitzgerald, H., Wang, Y., Wang, Q., Vergalasova, I., Elshaikh, M. A., … Hathout, L. (2021). Does prophylactic para-aortic lymphatic irradiation improve outcomes in women with stage IIIC1 endometrial carcinoma? A multi-institutional pooled analysis. Practical Radiation Oncology. -
Comparison of survival, acute toxicities, and dose-volume parameters between intensity-modulated radiotherapy with or without internal target volume delineation method and three-dimensional conformal radiotherapy in cervical cancer patients: A retrospective and propensity score-matched analysis.
Liang, Y.-Q., Feng, S.-Q., Xie, W.-J., Jiang, Q.-Z., Yang, Y.-F., Luo, R., … Xie, L.-X. (2021). Comparison of survival, acute toxicities, and dose-volume parameters between intensity-modulated radiotherapy with or without internal target volume delineation method and three-dimensional conformal radiotherapy in cervical cancer patients: A retrospective and propensity score-matched analysis. Cancer Medicine. -
Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian Cancer.
Eggold, J. T., Chow, S., Melemenidis, S., Wang, J., Natarajan, S., Loo, P. E., … Rankin, E. B. (2021). Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian Cancer. Molecular Cancer Therapeutics. -
Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy.
Rahimy, E., von Eyben, R., Lewis, J., Hristov, D., & Kidd, E. (1800). Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. -
Dose Prediction for Cervical Cancer Brachytherapy Using 3-D Deep Convolutional Neural Network
Ma, M., Kidd, E., Fahimian, B. P., Han, B., Niedermayr, T. R., Hristov, D., … Yang, Y. (2022). Dose Prediction for Cervical Cancer Brachytherapy Using 3-D Deep Convolutional Neural Network. IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES, 6(2), 214–221. -
Imaging to optimize gynecological radiation oncology.
Kidd, E. A. (2022). Imaging to optimize gynecological radiation oncology. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 32(3), 358–365. -
Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
Marar, M., Simiele, E., Niedermayr, T., & Kidd, E. A. (2022). Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry. International Journal of Radiation Oncology, Biology, Physics. -
Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival
Mendoza, M., Janchenko, L., von Eyben, R., Kidd, E., Pollom, E., Chang, S., … Soltys, S. (2022). Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS. -
Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas.
Sherertz, T., Jhingran, A., Biagioli, M., Gaffney, D., Elshaikh, M., Coleman, R. L., … Small, W. (2022). Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. -
Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.
Harkenrider, M., Fields, E., Chopra, S., Damast, S., Kidd, E. A., & Chino, J. (2023). Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 115(2), 269–275. -
The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma: A Pooled Data Analysis.
Patrich, T., Wang, Y., Elshaikh, M. A., Zhu, S., Damast, S., Li, J. Y., … Hathout, L. (2023). The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma: A Pooled Data Analysis. American Journal of Clinical Oncology. -
SHORT COURSE ADJUVANT VAGINAL CUFF BRACHYTHERAPY IN EARLY ENDOMETRIAL CANCER: ADVERSE EVENTS AND EARLY PATIENT REPORTED OUTCOMES
Burt, L., Huang, J., Boucher, K., Suneja, G., Decesaris, C., Grant, J., … Gaffney, D. (2022). SHORT COURSE ADJUVANT VAGINAL CUFF BRACHYTHERAPY IN EARLY ENDOMETRIAL CANCER: ADVERSE EVENTS AND EARLY PATIENT REPORTED OUTCOMES. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. BMJ PUBLISHING GROUP. -
Dosimetric Evaluation of OARs from SAVE Protocol.
Kunz, J. N., Huang, Y. J., Casper, A. C., Suneja, G., Burt, L. M., Jhingran, A., … Gaffney, D. K. (2023). Dosimetric Evaluation of OARs from SAVE Protocol. International Journal of Radiation Oncology, Biology, Physics. -
Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency.
Marar, M., Niedermayr, T., & Kidd, E. (2023). Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency. International Journal of Radiation Oncology, Biology, Physics. -
Adjuvant radiation therapy in early-stage endometrial cancer with abnormal beta-catenin expression is associated with improved local control.
Hui, C., Mendoza, M. G., Snyder, J., Dorigo, O., Litkouhi, B., Renz, M., … Kidd, E. A. (2023). Adjuvant radiation therapy in early-stage endometrial cancer with abnormal beta-catenin expression is associated with improved local control. Gynecologic Oncology, 174, 42–48. -
Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancer in the United States.
Taparra, K., Ing, B. I., Ewongwo, A., Vo, J. B., Shing, J. Z., Gimmen, M. Y., … Kidd, E. (2023). Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancer in the United States. Cancers, 15(9). -
Does lymph node assessment change the prognostic significance of substantial LVSI and p53 status in endometrial endometrioid carcinoma?
Hui, C., Mendoza, M. G., von Eyben, R., Dorigo, O., Litkouhi, B., Renz, M., … Kidd, E. (2023). Does lymph node assessment change the prognostic significance of substantial LVSI and p53 status in endometrial endometrioid carcinoma? Gynecologic Oncology, 177, 150–156. -
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial.
Gensheimer, M. F., Gee, H., Shirato, H., Taguchi, H., Snyder, J. M., Chin, A. L., … Diehn, M. (2023). Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial. JAMA Oncology. -
Development and clinical implementation of simple needle attachment post placement interstitial template (SNAPP-IT) enabling a shorter, more direct needle path while preserving tumor visualization.
Baniel, C. C., Hui, C., Franco, P. A., Niedermayr, T., & Kidd, E. A. (2023). Development and clinical implementation of simple needle attachment post placement interstitial template (SNAPP-IT) enabling a shorter, more direct needle path while preserving tumor visualization. Brachytherapy. -
Prognostic impact of mismatch repair status in early-stage endometrial cancer treated with adjuvant radiation: a multi-institutional analysis.
Hathout, L., Sherwani, Z. K., Alegun, J., Ohri, N., Fields, E. C., Shah, S., … Damast, S. (2024). Prognostic impact of mismatch repair status in early-stage endometrial cancer treated with adjuvant radiation: a multi-institutional analysis. International Journal of Radiation Oncology, Biology, Physics. -
Design approach and benefits of the 3D-printed vaginal individualized applicator (VIA).
Ewongwo, A., Niedermayr, T., & Kidd, E. A. (2024). Design approach and benefits of the 3D-printed vaginal individualized applicator (VIA). Brachytherapy. -
Less than whole uterus irradiation for patients with locally advanced cervical cancer.
Hui, C., Ewongwo, A., Mendoza, M. G., Kozak, M. M., Jackson, S., Fu, J., & Kidd, E. (2024). Less than whole uterus irradiation for patients with locally advanced cervical cancer. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 110199. -
Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients.
Nief, C. A., Hammer, P. M., Wang, A., Charu, V., Tanweer, A., Litkouhi, B., … Howitt, B. E. (2024). Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. -
The Assistant Clinical Research Coordinator Program: A Pathway for Recruitment in Radiation Oncology.
Aboytes, M., Cody, M., Laseinde, E., Hall, J., Soltys, S., Beadle, B., … Pollom, E. L. (2024). The Assistant Clinical Research Coordinator Program: A Pathway for Recruitment in Radiation Oncology. Advances in Radiation Oncology, 9(7), 101504. -
3D-printed vaginal individualized applicator (VIA) simplifies procedure and optimizes dosimetry for gynecologic interstitial brachytherapy
Niedermayr, T., & Kidd, E. (2023). 3D-printed vaginal individualized applicator (VIA) simplifies procedure and optimizes dosimetry for gynecologic interstitial brachytherapy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. BMJ PUBLISHING GROUP. -
Less than whole uterus irradiation for locally advanced cervical cancer maintains locoregional control and decreases radiation dose to bowel
Kidd, E., Hui, C., Ewongwo, A., & Mendoza, M. (2023). Less than whole uterus irradiation for locally advanced cervical cancer maintains locoregional control and decreases radiation dose to bowel. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. BMJ PUBLISHING GROUP. -
Prognostic performance of FIGO 2023 endometrial carcinoma staging: a comparison to FIGO 2009 staging in the setting of known and unknown molecular classification.
Libert, D., Hammer, P. M., Hui, C., Kidd, E. A., Folkins, A. K., Longacre, T., … Howitt, B. E. (2024). Prognostic performance of FIGO 2023 endometrial carcinoma staging: a comparison to FIGO 2009 staging in the setting of known and unknown molecular classification. Histopathology. -
Parametric response mapping of co-registered intravoxel incoherent motion magnetic resonance imaging and positron emission tomography in locally advanced cervical cancer undergoing concurrent chemoradiation therapy
Capaldi, D. P. I., Wang, J.-Y., Liu, L., Sheth, V. R., Kidd, E. A., & Hristov, D. H. (2024). Parametric response mapping of co-registered intravoxel incoherent motion magnetic resonance imaging and positron emission tomography in locally advanced cervical cancer undergoing concurrent chemoradiation therapy. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 31. -
Parametric response mapping of co-registered intravoxel incoherent motion magnetic resonance imaging and positron emission tomography in locally advanced cervical cancer undergoing concurrent chemoradiation therapy.
Capaldi, D. P., Wang, J.-Y. Y., Liu, L., Sheth, V. R., Kidd, E. A., & Hristov, D. H. (2024). Parametric response mapping of co-registered intravoxel incoherent motion magnetic resonance imaging and positron emission tomography in locally advanced cervical cancer undergoing concurrent chemoradiation therapy. Physics and Imaging in Radiation Oncology, 31, 100630. -
Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial.
DeCesaris, C., Wilson, T., Kim, J., Burt, L., Grant, J., Harkenrider, M. M., … Gaffney, D. (2024). Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Practical Radiation Oncology. -
Diabetes mellitus complications associated with recurrence of stage I endometrioid endometrial cancer: A single-center retrospective study.
Nief, C. A., Long, S. E., McCleary, T.-L. L., Kidd, E., Litkouhi, B., & Howitt, B. (2024). Diabetes mellitus complications associated with recurrence of stage I endometrioid endometrial cancer: A single-center retrospective study. Gynecologic Oncology, 190, 298–306. -
Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update.
Fields, E. C., Bosch, W. R., Albuquerque, K. V., Bhatia, R., Chino, J., Dyer, B., … Fisher, C. M. (2024). Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update. Practical Radiation Oncology. -
Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the American brachytherapy society.
Kidd, E. A., Butler, S. S., Gardner, U., & Viswanathan, A. N. (2024). Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the American brachytherapy society. Brachytherapy. -
Executive Summary of the American Radium Society Appropriate Use Criteria for Locally Advanced and Oligometastatic Cervical Cancer: Systematic Review and Updated Guidelines
Venkatesulu, B. P., Saripalli, A., Jhingran, A., Son, C., Grossman, C., Yashar, C., … Small, W. (2024). Executive Summary of the American Radium Society Appropriate Use Criteria for Locally Advanced and Oligometastatic Cervical Cancer: Systematic Review and Updated Guidelines. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
-
Intratumoral metabolic heterogeneity of cervical cancer
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
- Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
- Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
- Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer
Practice Locations
Radiation Oncology at Blake Wilbur Building Palo Alto, CA
Palo Alto, CA
Radiation Oncology at Blake Wilbur Building
875 Blake Wilbur Dr
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereCyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur Palo Alto, CA
Palo Alto, CA
CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur
875 Blake Wilbur Dr
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(104 reviews)
Excellent care
My tean, was absolutely lovely. I left with a ear to ear smile on my face. Thank you...
Elizabeth was very thorough with explaining procedure and she was very easy to understand. Looking forward to meeting her in person.
She is excellent. Explains things and answers questions thoroughly.
She's pretty wonderful. In addition to being a great and insightful communicator, she spoke to our logistics treatment needs with grace. I spoke of her attributes on the previous page: personable, articulate, knowledgeable, empathic, eloquent, problem solver.
She is very nice and professional
Dr. Kidd was very interested in my case and informative. She took her time with me to explain her findings and listened to my concerns. I appreciated her knowledge and compassion. My thanks go to her and her staff.
Dr. Kidd and staff were thorough. I received excellent information during the video visit.
Dr. Kidd, Nurse Karen, the Dr. in training, and all staff was excellent.
Warm and informative.
Dr. Kidd shared all the information needed for my upcoming treatments. My daughter was present with me and we could ask questions.
Dr. Kidd was straight forward and direct with the treatment and side effects. This is very necessary to keep my particular cancer from reoccurring!
She was very caring and explained everything in a way that was easy for me to understand. I was very comfortable talking with her.
I very happy with her
Dr. Kidd was very professional, but took time to let me answer her questions, as well as letting me ask mine. This is a first for me so I was not familiar with radiation therapy. I feel she was able to explain the procedure to my satisfaction.
Attentive and professional .
Willing to evaluate benefit of treating.
Knowledgeable and thorough
I appreciated Dr. Kidd's explanation about my treatment options and visit notes summarizing additional intake details from Dr. Butler. I received excellent care during this visit from both of them.
Excellent. I feel I am in expert hands
Very knowledgeable and explain everything in detail to me.
I am looking forward to meeting her in person and feel confident I am in good hands with her.
Dr. Kidd needs to speak slowly.
Great doctor. Answered all my questions
She was concise in explaining bracky vs. external radiation. Explained the tumor board review. Understood my concerns of finances and caregiver/ travel needs.
I like Dr Kidd she has helped me very much and shows me she is concerned about my health I thank her very much for getting me back to being healthy
Wonderful
Dr. Kidd is caring and compassionate, as well as an excellent doctor.
Appreciated how easy she was to hear......hearing loss a big issue at this age. Video appointment started on time and was very efficient.
Clinical and informative.
Dr. Kidd let me know what my next steps would be for follow up treatment.
Dr. Kidd made this video visit possible by calling on the cell phone because while we could see and hear Dr Kidd and her nurse on the screen, our tablet would not open the speaker (needed an update).
She was quick to make a modification, and the conference was completed over cell phone speaker. Very attentive!
Thank you, Stanford Health & Dr Kidd.
Good listener, reassuring, clear, precise, confident. I don’t feel as anxious as before the visit with her. Thank you!
Thank you for the visit and instructions. Hoping to get this done and continue life.
Doc on time and efficient
I am so thankful for the not only the physical care but also the personal care all of your staff provide. I am so thankful for the services I have received. All of your staff are the best.
Very comfortable talking to her
Dr. Kidd is amazing. Grateful for her care and diligence in helping me through cancer.
She was very prepared, had looked into the history of my mother.
Excellent Doctors and staff
Her and her staff always take time to listen to you. They are never rushed. They help with getting problems solved with other Stanford providers.
Good staff
Dr. Kidd is the best
Great Medical Advice and Medical Service provided by Dr. Elizabeth Kidd!!
Dr. Kidd is one of the best doctors I have ever met. Her care and true concern for my health is the best.
Since Dr. Kidd is a very specific specialty, I doubt I would have the opportunity to rec. her.
Dr. Kidd is superlative on every level and in every way. Her expertise, manner, communication skills, caring nature are exemplary. I feel so fortunate to be her patient.
I like that the doctor was not rushed and took I time to answer all my questions.
All the personnel very attentive.
Dr. Kidd was very thorough, in her discussion of my care and her recommendations; I had very few additional questions!
Explained procedures well. Asked me if I wanted to participate in a trial.
Dr. Elizabeth Kidd was thorough & efficient.
Very good.
Everyone in the room during my visit answered my questions fully and adequately. I was concerned about side effects of the procedure both short term & long term and they answered it truthfully.
All good.
Dr. Amer Karam - Great. Dr. Kidd - Great.
Awesome.
Excellent experience.
Never had a bad experience with the doctor or her phy. assistants.
Dr. Kidd is the best!
Good experience! She was excellent.
All excellent.
Great doctor. (Dr. Kidd).
I feel very satisfied well I am inspired with a lot of confidence.
Dr. Kidd has been consistently an excellent doctor (P.C. care provider). She is extremely knowledgeable, yet personable.
As a physician, I found Dr. Kidd to be outstanding with patience, personal clarity of explanations, thorough, wonderful attribute.
I've been coming to Stanford two years and love the docs and nurses I have had so far.
My care providers are primarily Elizabeth Kidd and her RN nurse... April Mark. I cannot ever praise them enough. They are like real friends to me.
Dr. Kidd is a wonderful, careful, and caring physician. She gave me her full attention and suggested practical approaches to my health concerns.
I would recommend it others very much if medical care was needed.
Everyone very friendly & very courtesy.
Dr. Kidd has been there for me.
Good.
Good.
Dr. Kidd is great. I would unequivocally recommend her to others.
Very good experience I recommend to any person.
Dr. Kidd is thorough, kind, brilliant and pleasant.
Very good.
Dr. Kidd is the most respectful, professional, and caring doctor. Always leave with a feeling that I have received the best care possible.
I credit Dr. Kidd as one of the drs. that has truly helped me!
All very good.
Dr. Kidd is brilliant, kind and caring.
Excellent attention.
medications are not an issue - Dr. Kidd is very, very good at explaining my condition and is always able to give me information which is helpful.
Even concerned over my husband as he patiently waited. Tired to make sure he was comfy.
Dr. Kidd is an outstanding doctor.
Good.
The dr. gives me lots of confidence and I feel comfortable with her.
Excellent attention.
Dr. Kidd is always professional and caring. Dr. Kidd always takes excellent care of me and addresses all my concerns very well. Dr. Kidd and her team are amazing!!! Thanks for the great care!
Felt that Dr. Kidd was happy and glad for my progress.
Care provider seemed a bit rushed. Many medical terms used & I had to ask clarifying questions & researched on "Google" when got home. "Fistula".
Good experience.
Dr. Kidd truly understands my health condition puts a lot of effort and exceeds all my treatment plans and future long term care knowing that she will provide absolutely the best care....
Very, very good.
I felt confident about the doctor's medical care, manner, and overall experience.
Dr. Kidd is the best.
She entirely failed to share important information. Patients have to be informed.
Highly recommended!
Even though I know Dr. Kidd is very busy and has lots of patients to attend to, I really appreciate the fact that she takes a little time to ask me if I have any travel plans. That's nice!
Truly a good person for me.
Very good they were excellent people.
Very friendly made me feel comfortable and relaxed and confident.
All good and kind to other like me.
Expert at inserting IV.
Always go away informed and happy.
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records